| Cell line name |
PD PaCa |
|---|
| Synonyms |
PDPaCa; Poorly Differentiated Pancreatic adenoCarcinoma; PD |
|---|
| Accession |
CVCL_8401 |
|---|
| Resource Identification Initiative |
To cite this cell line use: PD PaCa (RRID:CVCL_8401) |
|---|
| Comments |
Doubling time: ~18 hours (PubMed=3971476).
Derived from site: In situ; Pancreas; UBERON=UBERON_0001264. |
|---|
| Disease |
Hamster pancreatic ductal adenocarcinoma (NCIt: C133090) |
|---|
| Species of origin |
Mesocricetus auratus (Golden hamster)
(NCBI Taxonomy: 10036) |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=6805945
Barbara K. Chang, Robert Gutman;
Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
Cancer Res. 42:2666-2670(1982) PubMed=6435863
Barbara K. Chang, Owen Black Jr., Robert Gutman;
Inhibition of growth of human or hamster pancreatic cancer cell lines by alpha-difluoromethylornithine alone and combined with cis-diamminedichloroplatinum(II).
Cancer Res. 44:5100-5104(1984) PubMed=3971476; DOI=10.1007/BF00434351
Barbara K. Chang, Judith A. Gregory;
Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer.
Cancer Chemother. Pharmacol. 14:132-134(1985) PubMed=8863680; PMCID=PMC1865186
Nadina Erill, Miriam Cuatrecasas, Francisco J. Sancho, Antonio Farre, Parviz M. Pour, Felix Lluis, Gabriel Capella;
K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.
Am. J. Pathol. 149:1333-1339(1996) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54946764
|
|---|
| Entry history |
|---|
| Entry creation | 04-Apr-2012 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 10 |
|---|
